StrataGraft Market Report 2026

StrataGraft Market Overview

• The StrataGraft market growth in the historic period has been driven by increasing incidence of burn injuries, advancements in tissue engineering research • Market expansion is supported by expansion of regenerative medicine approvals, increasing demand for advanced wound care products • Growth Driver: Rising Incidence Of Chronic Wounds And Burn Injuries Driving Market Growth Due To Increasing Demand For Advanced Skin Graft Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under StrataGraft Market?

StrataGraft is a bioengineered, allogeneic skin substitute designed to treat deep partial-thickness burns and other complex skin defects. It is composed of both dermal and epidermal layers, made from human keratinocytes and dermal fibroblasts grown on a collagen scaffold. The main indication types of stratagraft are thermal burns and full-thickness burns. Thermal burns are injuries caused by heat, including flames, steam, or hot surfaces, resulting in damaged skin and tissues. The various formulations include allogeneic cultured keratinocytes and dermal fibroblasts. These are used by various end-users such as hospitals, specialized wound care centers, and outpatient care.

What Is The StrataGraft Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of regenerative medicine approvals, increasing demand for advanced wound care products, rising investments in bioengineered tissue platforms, growing focus on outpatient burn treatment solutions, continued innovation in skin substitute technologies. Major trends in the forecast period include increasing adoption of bioengineered skin substitutes, rising demand for advanced burn care solutions, growing focus on regenerative wound healing therapies, expansion of collagen-based scaffold technologies, enhanced emphasis on reduced autograft dependency.

Global StrataGraft Market Segmentation

1) By Indication: Thermal Burns, Full-Thickness Burns 2) By Formulation: Allogeneic Cultured Keratinocytes, Dermal Fibroblasts 3) By End User: Hospitals, Specialized Wound Care Centers, Outpatient Care

What Are The Drivers Of The StrataGraft Market?

The rising incidence of chronic wounds and burn injuries is expected to propel the growth of the stratagraft market going forward. Chronic wounds and burn injuries refer to conditions where skin or underlying tissue is damaged, with chronic wounds characterized by prolonged healing times due to factors such as diabetes or poor circulation, and burn injuries caused by exposure to thermal, chemical, or electrical agents that often require advanced medical treatment for repair and recovery. The increase in chronic wounds and burn injuries is driven by the rising prevalence of diabetes, obesity, an aging population, industrial accidents, and poor access to preventive care in many regions. Stratagraft serves as an advanced treatment option addressing chronic wounds and burn injuries by offering a bioengineered alternative to traditional skin grafts, promoting effective wound healing while reducing the need for donor site procedures. For instance, in October 2023, according to the World Health Organization (WHO), a US-based public health agency, globally, about 180,000 deaths are caused by burns annually, with the majority occurring in low- and middle-income countries. In the United States, there were an estimated 410,000 burn injuries in 2023, with approximately 40,000 requiring hospitalizations, making burn injuries a persistent public health concern. Therefore, the rising incidence of chronic wounds and burn injuries is driving growth in the stratagraft industry. The growing number of clinical trials is expected to propel the growth of the stratagraft market going forward. Clinical trials refer to structured research studies conducted to evaluate the effectiveness, safety, and potential side effects of medical treatments, drugs, or devices in humans. The increasing number of clinical trials reflects the growing complexity of healthcare needs, advancements in science, and the broader scope of medical research. Clinical trials support stratagraft by generating essential evidence on its safety, efficacy, and overall performance in treating severe burn injuries, helping to validate its ability to accelerate skin regeneration, reduce complications, and ultimately guide its regulatory approval and broader adoption in clinical practice. For instance, in December 2024, according to Association of the British Pharmaceutical Industry, a a UK-based trade organization that represents pharmaceutical manufacturers, the total number of industry-sponsored clinical trials initiated in the UK rose from 411 in 2022 to 426 in 2023, reflecting growing R&D activity that supports innovation in patient treatments and generates additional revenue streams for the NHS. Therefore, the rising number of clinical trials is driving the growth of the stratagraft industry. The increased healthcare spending is expected to propel the growth of the stratagraft market going forward. Healthcare spending refers to the financial resources allocated by individuals, businesses, governments, and other entities toward healthcare services and products. The increased healthcare spending is attributed to factors such as aging populations, the rising prevalence of chronic diseases, advancements in medical technology, and the growing demand for healthcare services and pharmaceuticals. Healthcare spending supports stratagraft by funding research and development for advanced wound care treatments, improving access to treatment for patients with critical burns and wounds, and ensuring insurance coverage for long-term management, thereby enhancing treatment availability and affordability. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, total health spending in Canada is anticipated to rise by 2.8% in 2023, following a modest growth of just 1.5% in 2022. Therefore, the increased healthcare spending is driving the growth of the stratagraft industry.

Key Players In The Global StrataGraft Market

Major companies operating in the stratagraft market are Mallinckrodt Pharmaceuticals plc

Regional Insights

North America was the largest region in the stratagraft market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the StrataGraft Market?

The stratagraft market consists of sales of bioengineered skin substitutes, dermal replacement Grafts. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the StrataGraft Market Report 2026?

The stratagraft market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the stratagraft industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.